Oxygen therapy in acute medical care
BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7351.1406 (Published 15 June 2002) Cite this as: BMJ 2002;324:1406
- Alastair J Thomson (a.j.thomson@ed.ac.uk), research fellow,
- David J Webb (d.j.webb@ed.ac.uk), Christison professor of therapeutics and clinical pharmacology,
- Simon R J Maxwell (s.maxwell@ed.ac.uk), senior lecturer,
- Ian S Grant (i.s.grant@ed.ac.uk), consultant anaesthetist
- Clinical Pharmacology Unit, Department of Medical Sciences, Western General Hospital, University of Edinburgh, Edinburgh EH4 2XU
- Intensive Care Unit, Western General Hospital
The potential dangers of hyperoxia need to be recognised
Oxygen is cheap, widely available, and used in a range of settings and conditions to relieve or prevent tissue hypoxia. Since its discovery by Scheele and Priestley in the 1770s, it has remained one of the most effective therapeutic agents available. However, as a result of poor prescribing and monitoring, inappropriate doses are often given.1
Oxygen is most commonly delivered by devices with variable performance such as face masks and nasal cannulae. These can produce unexpectedly high concentrations of inspired oxygen, particularly when ventilation is depressed.2 In addition, masks that incorporate a reservoir bag are often used in emergencies, following the widespread adoption of advanced trauma life support style (or ATLS) guidelines. These appliances can produce systemic hyperoxia that is generally assumed to be harmless. However, emerging evidence suggests that for some patients with acute medical conditions, hyperoxia may be harmful.
Oxygen therapy is often …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.